NCT05367206View on ClinicalTrials.gov

Neoadjuvant Chemotherapy Followed by Chemoradiation Versus Chemoradiation for Stage IIIC Cervical Cancer Patients: A Randomized Phase III Trial

PHASE3RecruitingINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

March 14, 2022

Primary Completion Date

March 31, 2024

Study Completion Date

March 31, 2027

Conditions
Cervical CancerNeoadjuvant ChemotherapyBulky Neoplasm
Interventions
DRUG

Albumin-Bound Paclitaxel

260mg/m2 q3w \*2 circles

DRUG

Carboplatin

AUC 5-6 q3w \* 2 circles

Trial Locations (1)

510000

RECRUITING

Sun Yat-sen University Cancer Center, Guangzhou

All Listed Sponsors
lead

Sun Yat-sen University

OTHER